chr5-132370065-C-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_003060.4(SLC22A5):c.93C>T(p.Pro31Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000167 in 1,613,278 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
 Genomes: 𝑓 0.000092   (  0   hom.,  cov: 33) 
 Exomes 𝑓:  0.0000089   (  0   hom.  ) 
Consequence
 SLC22A5
NM_003060.4 synonymous
NM_003060.4 synonymous
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.619  
Publications
0 publications found 
Genes affected
 SLC22A5  (HGNC:10969):  (solute carrier family 22 member 5) Polyspecific organic cation transporters in the liver, kidney, intestine, and other organs are critical for elimination of many endogenous small organic cations as well as a wide array of drugs and environmental toxins. The encoded protein is a plasma integral membrane protein which functions both as an organic cation transporter and as a sodium-dependent high affinity carnitine transporter. The encoded protein is involved in the active cellular uptake of carnitine. Mutations in this gene are the cause of systemic primary carnitine deficiency (CDSP), an autosomal recessive disorder manifested early in life by hypoketotic hypoglycemia and acute metabolic decompensation, and later in life by skeletal myopathy or cardiomyopathy. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -13 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55). 
BP6
Variant 5-132370065-C-T is Benign according to our data. Variant chr5-132370065-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 460420.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BP7
Synonymous conserved (PhyloP=0.619 with no splicing effect.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000920  AC: 14AN: 152220Hom.:  0  Cov.: 33 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
14
AN: 
152220
Hom.: 
Cov.: 
33
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.0000201  AC: 5AN: 248666 AF XY:  0.0000148   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
5
AN: 
248666
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00000890  AC: 13AN: 1460940Hom.:  0  Cov.: 31 AF XY:  0.0000124  AC XY: 9AN XY: 726806 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
13
AN: 
1460940
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
9
AN XY: 
726806
show subpopulations 
African (AFR) 
 AF: 
AC: 
12
AN: 
33462
American (AMR) 
 AF: 
AC: 
0
AN: 
44690
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26100
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39680
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
86228
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
52960
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
5766
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
1111708
Other (OTH) 
 AF: 
AC: 
1
AN: 
60346
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.498 
Heterozygous variant carriers
 0 
 1 
 2 
 3 
 4 
 5 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.0000919  AC: 14AN: 152338Hom.:  0  Cov.: 33 AF XY:  0.0000537  AC XY: 4AN XY: 74506 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
14
AN: 
152338
Hom.: 
Cov.: 
33
 AF XY: 
AC XY: 
4
AN XY: 
74506
show subpopulations 
African (AFR) 
 AF: 
AC: 
13
AN: 
41588
American (AMR) 
 AF: 
AC: 
0
AN: 
15308
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3472
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5180
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4832
European-Finnish (FIN) 
 AF: 
AC: 
0
AN: 
10630
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
292
European-Non Finnish (NFE) 
 AF: 
AC: 
0
AN: 
68012
Other (OTH) 
 AF: 
AC: 
1
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.514 
Heterozygous variant carriers
 0 
 1 
 2 
 3 
 4 
 5 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
ClinVar
Significance: Likely benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Jan 28, 2021
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Renal carnitine transport defect    Benign:1 
Jun 17, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.